Neuropsychiatric Disease and Treatment, published by DOVE MEDICAL PRESS LTD, is a prominent open access journal dedicated to advancing the field of neuropsychiatry. Since its inception in 2009, this journal has provided a platform for the dissemination of high-quality research on innovative therapies and treatments for neuropsychiatric disorders. With an impressive Q2 ranking in Psychiatry and Mental Health and a Q3 ranking in Biological Psychiatry as of 2023, it holds a reputable position within the scholarly community, reflecting its commitment to impactful research. The journal's open access model ensures widespread accessibility, fostering collaboration and dialogue among researchers, clinicians, and students worldwide. The journal accepts a variety of article types, including original research, reviews, and case studies, encompassing a range of topics from pathophysiology to therapeutic advancements. With its base in New Zealand and a Scopus rank placing it within the 69th percentile of Psychiatry and Mental Health, Neuropsychiatric Disease and Treatment is an essential resource for those dedicated to understanding and treating the complexities of neuropsychiatric conditions.

BJPsych Open, published by Cambridge University Press, is a leading open access journal dedicated to the field of psychiatry and mental health. Since its inception in 2015, the journal has provided a platform for disseminating cutting-edge research and evidence-based practices, making significant contributions to the academic community. With an impressive impact factor and currently ranking in the top Q1 quartile of its field, BJPsych Open is recognized for its rigor and relevance, ranking 138 out of 567 journals in psychiatry and mental health according to Scopus, placing it in the 75th percentile. The journal's commitment to open access enhances visibility and accessibility, ensuring that vital research is available to a global audience. Researchers, professionals, and students alike will find valuable insights into contemporary mental health challenges and innovative treatment approaches, making BJPsych Open an essential resource for advancing mental health scholarship.

Research in Autism Spectrum Disorders, an esteemed journal published by ELSEVIER SCI LTD, is dedicated to advancing the understanding of autism spectrum disorders through innovative research and scholarly articles. Since its inception in 2007, the journal has carved out a distinguished place in the field, reflected in its robust 2023 Impact Factor and Q2 ranking in key categories such as Clinical Psychology, Developmental and Educational Psychology, and Psychiatry and Mental Health. By bridging the gap between research and practice, this journal serves as a vital resource for researchers, professionals, and students alike, fostering collaboration and knowledge-sharing among those dedicated to improving outcomes for individuals with autism. Featuring a broad scope that encompasses various aspects of autism research, the journal remains committed to publishing high-quality studies that drive the conversation forward in this critical area of study. Access options for the journal's content are available under the Elsevier guidelines, ensuring that pivotal research reaches a wide audience.

Autism Research, published by WILEY, is a premier academic journal dedicated to advancing the understanding of autism spectrum disorders (ASD) through high-quality research and clinical studies. With the ISSN 1939-3792 and E-ISSN 1939-3806, this journal has been integral to the field since its inception in 2008 and has been consistently ranked in the Q1 quartile across categories such as Genetics (clinical), Neurology (clinical), and various facets of Neuroscience. Holding prominent Scopus ranks, including #18 in Genetics (clinical) and #26 in General Neuroscience, Autism Research provides a vital platform for researchers, clinicians, and students alike to disseminate innovative findings and foster collaborations aimed at improving diagnosis and treatment strategies for individuals with autism. While not an open access journal, it offers a blend of insightful articles and impactful research that is essential for professionals seeking to stay at the forefront of this rapidly evolving field.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.

Asia-Pacific Psychiatry is a leading academic journal published by WILEY, focused on the diverse and rapidly evolving fields of psychiatry and mental health within the Asia-Pacific region. With an ISSN of 1758-5864 and an E-ISSN of 1758-5872, this journal has been recognized for its significant impact, holding a Q1 ranking in Medicine (miscellaneous) and a Q2 ranking in Psychiatry and Mental Health as of 2023. Its commendable Scopus ranking places it at Rank #83 out of 567 in its category, highlighting its influence and relevance in contemporary research. The journal aims to facilitate the dissemination of high-quality research, reviews, and clinical insights that address mental health challenges, promote global understanding, and encourage collaboration among professionals and academics. Although it is not an open-access journal, the high impact factor underscores its value in the scholarly community, making it an essential resource for researchers, clinicians, and students dedicated to enhancing mental health practices and policies in the region and beyond.

Adolescent Research Review, published by SPRINGER INT PUBL AG, is a leading academic journal dedicated to advancing the understanding of adolescent development across multiple disciplines, including Developmental and Educational Psychology, Pediatrics, Psychiatry, and Social Sciences. With an impressive impact factor, this journal ranks Q1 in four critical categories, reflecting its commitment to high-quality research and its influential role within the academic community. Since its inception in 2016, it has become an essential resource for researchers, professionals, and students seeking to explore the complexities of adolescence. The journal not only highlights innovative studies and theoretical advancements but also fosters interdisciplinary dialogue that informs policies and practices surrounding youth. With an assimilative approach to various fields, Adolescent Research Review serves as a vital platform for groundbreaking research that seeks to improve the well-being of adolescents worldwide.

JOURNAL OF CLINICAL CHILD AND ADOLESCENT PSYCHOLOGY, published by Routledge Journals, Taylor & Francis LTD, is a premier, peer-reviewed academic journal dedicated to the fields of clinical psychology, developmental, and educational psychology. With an impressive impact factor reflecting its esteemed reputation, this journal is currently ranked Q1 in both Clinical Psychology and Developmental and Educational Psychology categories, showcasing its significant contribution to the advancement of knowledge in these disciplines. Covering a convergence period from 1999 to 2024, it serves as a vital resource for researchers and practitioners seeking to explore innovative interventions, evidence-based practices, and developmental theories relevant to children and adolescents. Accessible from the United States and adhering to rigorous academic standards, this journal invites contributions that facilitate understanding and improvement of psychological health in youth, making it an indispensable tool for professionals dedicated to shaping the future of mental health.

The Scandinavian Journal of Child and Adolescent Psychiatry and Psychology is a premier platform for disseminating significant research in the fields of child and adolescent mental health. Published by SCIENDO, this journal has embraced an Open Access model since 2013, promoting wider accessibility to vital findings and discussions in this pivotal area of study. With a unique focus on issues facing young individuals, it aims to bridge gaps between research, clinical practice, and policy-making. The journal invites submissions from researchers, clinicians, and practitioners worldwide, ensuring a diverse range of perspectives and contributions. By fostering scholarly dialogue and innovation, it plays an essential role in advancing knowledge and improving outcomes in child and adolescent psychiatry and psychology, making it a crucial resource for anyone invested in the mental well-being of young populations.

Developmental Neurorehabilitation is an esteemed journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental neuroscience and rehabilitation. With an ISSN of 1751-8423 and an E-ISSN of 1751-8431, this journal serves as a vital resource for researchers, clinicians, and students interested in innovative therapeutic approaches and rehabilitation techniques for children and adolescents. Since its inception in 1997, Developmental Neurorehabilitation has focused on disseminating high-quality research, contributing to a deeper understanding of recovery processes in developmental disorders, and facilitating interdisciplinary dialogue among professionals. With its recognition in Q2 and Q3 quartiles across prominent categories such as Pediatrics and Rehabilitation, it stands out as a pivotal publication in its field, boasting Scopus rankings that reflect its significant impact—ranked #53 in Rehabilitation and #139 in Pediatrics, among others. While maintaining a commitment to quality research, the journal does not currently offer open access but remains accessible through institutional subscriptions, further enriching the academic landscape with critical insights into rehabilitation methodologies for developmental challenges and promoting better clinical practices to improve patient outcomes.